- Home
- ITIC vs MGTX Comparison
ITIC vs MGTX Comparison
Compare ITIC & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- MGTX
- Stock Information
- Founded
- ITIC 1972
- MGTX 2015
- Country
- ITIC United States
- MGTX United States
- Employees
- ITIC N/A
- MGTX N/A
- Industry
- ITIC Specialty Insurers
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITIC Finance
- MGTX Health Care
- Exchange
- ITIC Nasdaq
- MGTX Nasdaq
- Market Cap
- ITIC 404.7M
- MGTX 479.9M
- IPO Year
- ITIC N/A
- MGTX N/A
- Fundamental
- Price
- ITIC $228.05
- MGTX $6.26
- Analyst Decision
- ITIC
- MGTX Strong Buy
- Analyst Count
- ITIC 0
- MGTX 2
- Target Price
- ITIC N/A
- MGTX $23.50
- AVG Volume (30 Days)
- ITIC 12.7K
- MGTX 337.9K
- Earning Date
- ITIC 02-11-2025
- MGTX 03-13-2025
- Dividend Yield
- ITIC 6.95%
- MGTX N/A
- EPS Growth
- ITIC 22.45
- MGTX N/A
- EPS
- ITIC 15.10
- MGTX N/A
- Revenue
- ITIC $241,018,000.00
- MGTX $13,929,000.00
- Revenue This Year
- ITIC N/A
- MGTX N/A
- Revenue Next Year
- ITIC N/A
- MGTX $1,391.84
- P/E Ratio
- ITIC $15.10
- MGTX N/A
- Revenue Growth
- ITIC 1.93
- MGTX 108.24
- 52 Week Low
- ITIC $146.41
- MGTX $3.85
- 52 Week High
- ITIC $290.40
- MGTX $7.37
- Technical
- Relative Strength Index (RSI)
- ITIC 39.00
- MGTX 53.41
- Support Level
- ITIC $225.24
- MGTX $5.66
- Resistance Level
- ITIC $231.29
- MGTX $6.12
- Average True Range (ATR)
- ITIC 6.06
- MGTX 0.39
- MACD
- ITIC 0.26
- MGTX -0.02
- Stochastic Oscillator
- ITIC 58.01
- MGTX 62.26
About ITIC Investors Title Company
Investors Title Co operates primarily in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment primarily issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.